Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Porsche’s Electric Vehicle Strategy Stalls, Sending Shockwaves Through Volkswagen Group

Andreas Sommer by Andreas Sommer
September 28, 2025
in Stocks
0
Porsche Holding Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

The ambitious electric vehicle roadmap at luxury automaker Porsche AG has hit significant roadblocks, creating substantial financial headwinds for its parent company, Volkswagen Group, and major shareholder Porsche Holding. This marks the fourth profit warning issued this year, raising serious concerns about the financial stability of the entire corporate family.

Financial Forecasts Slashed Amid Waning EV Demand

Faltering consumer interest in key global markets and intense competitive pressure in China have forced Porsche AG to postpone the launch of several planned all-electric models. In a dramatic revision of its financial outlook, the sports car manufacturer now anticipates an operating margin of no more than 2% for 2025, a sharp decline from its previous projection of 5% to 7%. This strategic pivot necessitates significantly higher depreciation and provisions, estimated to reach up to 1.8 billion euros.

The repercussions extend directly to the Volkswagen Group, which anticipates a financial impact of approximately 5.1 billion euros from this comprehensive product overhaul. Consequently, Volkswagen has also been compelled to lower its own profit margin guidance to a range of 2% to 3%.

Should investors sell immediately? Or is it worth buying Porsche Holding?

Porsche Holding Faces Substantial Earnings Downgrade

As the single largest shareholder in Volkswagen Group, Porsche Holding is experiencing a direct and severe deterioration in its financial prospects. The holding company has issued a major correction to its own projected annual post-tax profit. The new forecast has been adjusted downward to a range of 900 million to 2.9 billion euros, a substantial reduction from the earlier estimate of 1.6 billion to 3.6 billion euros. The market responded immediately to this news, with the company’s shares declining.

This situation at Porsche underscores the immense pressure facing the entire automotive industry. The transition to electric mobility is proving to be more costly and complex than initially anticipated, particularly for premium brands. Porsche Holding’s fortunes remain intrinsically linked to these sector-wide challenges, leaving investors to question its ability to navigate the ongoing turbulence. Recent developments suggest a prolonged period of difficulty for all entities involved.

Ad

Porsche Holding Stock: Buy or Sell?! New Porsche Holding Analysis from March 25 delivers the answer:

The latest Porsche Holding figures speak for themselves: Urgent action needed for Porsche Holding investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Porsche Holding: Buy or sell? Read more here...

Tags: Porsche Holding
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Nevro Stock

Nevro Shares Face Mounting Pressure as Fundamentals Worsen

AMD Stock

AMD's Strategic Alliance with Cohere: A Calculated Challenge to Nvidia's AI Dominance

Commercial Vehicle Stock

US Tariff Move Sparks Hope for Commercial Vehicle Group's Recovery

Recommended

Asep Medical Stock

Asep Medical Secures New Funding to Advance Diagnostic Pipeline

2 weeks ago
Finance_Fiscal (2)

SoFi Technologies Quarterly Earnings and Stock Performance

2 years ago
Newmont Mining Stock

Newmont Shares Surge as Gold Reaches Unprecedented Heights

6 months ago
IT-Healthcare

Analyst Upgrades Price Target for Elevance Health Reflecting Optimism and Strong Performance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

Trending

Pagerduty Inc Stock
AI & Quantum Computing

PagerDuty Charts a New Course with Autonomous AI Systems

by Kennethcix
March 25, 2026
0

PagerDuty Inc. is making a decisive push into artificial intelligence, aiming to redefine IT operations through radical...

Lexaria Bioscience Stock

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

March 25, 2026
Watsco Stock

Watsco’s Dividend Hike Contrasts with Operational Headwinds

March 25, 2026
Pinduoduo Stock

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

March 25, 2026
XPeng Stock

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • PagerDuty Charts a New Course with Autonomous AI Systems
  • Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution
  • Watsco’s Dividend Hike Contrasts with Operational Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com